Pazopanib Hydrochloride in Treating Patients With Von Hippel-Lindau Syndrome
NCT01436227
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Von Hippel-Lindau Syndrome
Interventions
OTHER:
Laboratory Biomarker Analysis
DRUG:
Pazopanib Hydrochloride
Sponsor
M.D. Anderson Cancer Center
Collaborators
[object Object]